Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 (Nature Communications, (2020), 11, 1, (5214), 10.1038/s41467-020-19055-7)

Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, Jianying Liu, Ping Ren, Mini Balakrishnan, Tomas Cihlar, Chien Te K. Tseng, Shinji Makino, Vineet D. Menachery, John P. Bilello, Pei Yong Shi

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this Article contained an error in the Acknowledgements, which incorrectly listed the NIH grant ‘AI142759’. This has been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish (US)
Article number3984
JournalNature communications
Volume12
Issue number1
DOIs
StatePublished - Dec 2021

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Fingerprint

Dive into the research topics of 'Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 (Nature Communications, (2020), 11, 1, (5214), 10.1038/s41467-020-19055-7)'. Together they form a unique fingerprint.

Cite this